Categories
API and Related Substances
API Intermediates
- Canagliflozin Intermediates
- Empagliflozin Intermediates
- Sofosbuvir Intermediates
- Ledipasvir Intermediates
- Efinaconazole intermediates
- Ketorolac Intermediates
- Formoterol Intermediates
Specialty/Fine Chemicals
Contact Us
Address: Room 305, Building 11, Jiangyue Road 999, Minhang District, Shanghai, China.
Tel: 86-021-26018649
Mobile: 17721318029
Fax: 86-021-26018649
QQ: 2899427924
Site: www.renshipharma.com
E-mail: info@renshipharma.com
Tel: 86-021-26018649
Mobile: 17721318029
Fax: 86-021-26018649
QQ: 2899427924
Site: www.renshipharma.com
E-mail: info@renshipharma.com
News
-
Japan Clears First All-Oral Hepatitis C (Daclatasvir & Asunaprevir) Treatment Aug 1, 2014 -
Top 15 NIH-funded disease areas Jul 25, 2014 -
Healthy future for China’s drug market Jul 12, 2014 -
FDA Publishes Guidance on ANDA Submissions Jul 12, 2014 -
Tomorrow's cardio blockbusters: Inside 'the next big leap' in controlling cholesterol Jul 12, 2014 -
When will Big Pharma get serious about antibiotic R&D? Jul 12, 2014